[Current status and prospect of metabonomics].
Xu
Min
M
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Lin
Dong-Hai
DH
Liu
Chang-Xiao
CX
D000818:Animals; D014408:Biomarkers, Tumor; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008660:Metabolism / Q000235:genetics / Q000502:physiology*; D009369:Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D010363:Pattern Recognition, Automated; D025341:Principal Component Analysis; D049490:Systems Biology; D015262:Xenobiotics / Q000378:metabolism / Q000633:toxicity*
D014408:Biomarkers, Tumor; D015262:Xenobiotics